- FOUNDED 2009
Overview
The Neuroendocrine Tumours Group is concerned with the management of neuroendocrine tumours (NETs). NETs are composed of neuroendocrine cells that produce and secrete regulatory hormones and are present throughout the nervous and endocrine systems. NETs can occur at many sites in the body, but they are most common in the digestive system. NETs are uncommon tumours that have many unusual features.
This group recognises the difficulty in providing quality multidisciplinary care for patients suffering from NETs. It aims to provide a platform for discussing NET-related issues and to advocate for the care of patients with NETs.
Group information
[Chair] Dr David Chan, Royal North Shore Hospital, NSW
Dr Gabby Cehic, The Queen Elizabeth Hospital, SA
Ms Erin Laing, Peter MacCallum Cancer Centre, VIC
A/Prof Michael Michael, Peter MacCallum Cancer Centre, VIC
Prof Tim Price, The Queen Elizabeth Hospital, SA
Ms Kate Wakelin, NeuroEndocrine Cancer Australia, VIC
A/Prof David Wyld, Royal Brisbane Hospital, QLD
Read the Neuroendocrine Tumour Group Terms of Reference
Read the AGM Minutes from 1 November 2023
Read the AGM Minutes from 22 November 2021
Read the AGM Minutes from 23 November 2020
What’s the latest
Group Chair
Group Chair
David Chan
Neuroendocrine Tumours Group Chair
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow
COSAoncology 15 hours ago
Congratulations David Thomas for recognition of your leadership and groundbreaking work in genomics in cancer care. And congratulations to all the recipients of the 2024 Premier's Awards for Outstanding Cancer Research.#cancerNSWawards https://t.co/7oNiXcKA3n
Read More >COSAoncology 16 hours ago
Congratulations Ashfaq Chauhan for recognition of your work to enhance cancer care for people from CALD backgrounds. https://t.co/HUi1nsuuzX
Read More >COSAoncology 16 hours ago
Congratulations @DrNicolasHart for recognition of your work to improve outcomes of all people affected by cancer. https://t.co/7QQoSk0bvf
Read More >COSAoncology 16 hours ago
Congratulations @yapml for recognition of your important work in equity and cancer care. https://t.co/Wli1hzRDxv
Read More >COSAoncology 6 days ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 in Melbourne, 6-7 March. We particularly welcome submissions from survivors themselves and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF pic.twitter.com/vjp4hfcVXN
Read More >COSAoncology 7 days ago
You have till this Friday 22 Nov '24 to submit an abstract for the National Cancer Survivorship Conference #Surv25 to be held in Melbourne, March 2025. We particularly welcome submissions from survivors and those whose work is in partnership with survivors https://t.co/6V4F3x1vvF https://t.co/87PUAMTxwA
Read More >COSAoncology 10 days ago
It's a wrap! Thanks to everyone who made #COSA24 a huge success, not least the almost 900 delegates who joined us on the Gold Coast. Watch the video for all the stats. pic.twitter.com/ysZNul66qH
Read More >COSAoncology 10 days ago
@sdent_cardioonc spent many years providing cancer care in Ontario Canada and was delighted to take home @garvey_gail's 'Indigenous and Tribal Peoples and Cancer' from #COSA24. @sdent_cardioonc shared her expertise on cardiovascular multimorbidity and cancer at the ASM. https://t.co/1Db1QSn3py
Read More >COSAoncology 10 days ago
Job well done! #COSA24 Co-convenors Michael Powell and Sean Hill delivered an amazing meeting. Time to relax ... almost. See what's left on the program https://t.co/ACGrZGt2Ee pic.twitter.com/NVi9bY1fiL
Read More >COSAoncology 10 days ago
You won't want to miss the #COSA24 plenary on AI in Healthcare with presenters @thedeanh @dhansen35 and Prof Catherine Jones. Followed by a panel discussion at Q&A. Today at 1:30pm pic.twitter.com/AEgtwaqSIS
Read More >